Company: HURA
Filing Date: 2025-02-07
Form Type: S-4
Source: 0001193125-25-022803
Chunk: 779

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-02-07
Form: S-4
Chunk 779
---
 net operating loss carryforwards of approximately $ 43,968,000 . Approximately $ 15,218,000 of the loss carryforwards will expire through 2037 , unless previously utilized. The remaining $ 28,750,000 of loss carryforwards do not expire. Utilization of the net operating loss carryforwards and credits may be subject to a substantial annual limitation due to the ownership change limitations provided by the IRC, and similar state provisions. The Company has not performed a detailed analysis to determine whether an ownership change under Section 382 of the IRC has occurred, but believes it to be likely. The effect of an ownership change would be the imposition of an annual limitation on the use of the loss carryforwards.

F- 58

TUHURA BIOSCIENCES, INC. AND SUBSIDIARY Notes to the consolidated financial statements For the years ended December 31, 2023, and 2022

Note 9—Stockholders’ equity

The Company has two classes of stock defined in its Amended and Restated Articles of Incorporation (the “Articles”).

Common Stock – Holders of common stock are entitled to onevote for each share of common stock.

Preferred Stock – The Company is authorized to issue up to 150,000,000 shares of Preferred Stock based on the Articles. The Company has three classes of Preferred Stock: Series A, Series A-1, and Series B. See below for a summary of the rights and preferences for the Company’s Preferred Stock:

| i. | Accrues dividends whether or not declared, are cumulative, and are payable only if declared by the Board of Directors. The Series A and SeriesA-1preferred stock accrue dividends at a rate of $0.0208and $0.0264, per annum respectively. Accrued, but unpaid Series A andA-1dividends totaled approximately $5,570 ,000as of December 31, 2023. The Series B preferred stock accrues dividends at a rate of $0.066for the first two years. After the second anniversary, Series B stock accrues dividends at a rate of $0.0264per annum. Accrued but unpaid Series B dividends totaled approximately $3,594,000as of December 31, 2023. |

| ii. | Has liquidation preferences over common stock; |

| iii. | Is convertible into common stock, at the option of the holder, subject to adjustments, as defined